Fulcrum Therapeutics Inc (FULC)       4.92  +0.02 (+0.41%)

4.92  +0.02 (+0.41%)

US3596161097 - Common Stock - After market: 4.92 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 28.94. This target is 488.26% above the current price.
FULC was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about FULC.
In the previous month the buy percentage consensus was at a similar level.
FULC was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 4.927.0729.0728.9445.15 - 43.70% 490.85% 488.26% 817.68%

Up and Down Grades

Date Firm Action Rating
2022-06-13 HC Wainwright & Co. Maintains Buy
2022-05-17 Morgan Stanley Maintains Overweight
2022-04-12 Morgan Stanley Maintains Overweight
2022-03-08 Oppenheimer Initiate Outperform
2021-08-17 HC Wainwright & Co. Maintains Buy
2021-08-13 SVB Leerink Maintains Outperform
2021-08-11 Credit Suisse Maintains Outperform
2021-08-11 Morgan Stanley Upgrade Equal-Weight -> Overweight
2021-03-22 Credit Suisse Initiate Outperform
2021-03-08 Morgan Stanley Maintains Equal-Weight
2021-03-02 Stifel Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA